China Healthcare Weekly (Feb16)-Innovative Drug Is "Innocent" In Geopolitics, BeiGene's BTK, Jacobio
⬇ $Jacobio Pharmaceuticals(01167)$ - Due to US Draft Bill against CXO, Biotech's share price also plummeted, but they're "Innocent".Future BTK inhibitor market pattern shows the upper limit of BeiGene. Jacobio's outlook is not optimistic
Continue reading on Smartkarma:- https://www.smartkarma.com/insights/china-healthcare-weekly-feb16-innovative-drug-is-innocent-in-geopolitics-beigene-s-btk-jacobio?utm_source=tiger_community
By Xinyao (Criss) Wang, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/xinyao-criss-wang?utm_source=tiger_community
On Jacobio Pharmaceuticals (01167):- https://www.smartkarma.com/entities/jacobio-pharmaceuticals?utm_source=tiger_community
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
